- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- Careers
- News & Insights
- About
- Languages
Daniel F. Donovan III (Dan)
News 2 results
Recognition
June 15, 2020
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2020 Guide
In the News · Source: Bloomberg BNA
November 9, 2018
Dan Donovan discusses how major law firms are preparing clients for possible new hearings and investigations in the U.S. House in January
Events 7 results
Webinar
May 21, 2020
Congressional Investigations: A Bipartisan Conversation With Chief Counsels During the COVID-19 Pandemic
Webinar
November 28, 2018
Washington Insight: What Will Election 2018 Mean for Healthcare, Medical Device and Pharma Companies
Conference
November 13, 2018
11th Annual King & Spalding Pharmaceutical University
Insights 14 results
Client Alert
July 30, 2020
Trump Administration Continues to Promote Drug Importation as a Way to Lower the Cost of Prescription Drugs
Client Alert
May 6, 2020
Congressional Oversight of COVID-19 Serological Testing
Client Alert
April 27, 2020
With New Select Investigative Subcommittee, House Democrats Double Down on COVID-19 Oversight
Client Alert
April 27, 2020
Healthcare Provider Stimulus: Update on Public Health and Social Services Emergency Fund